Gene · 494336
Papers3,170
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,170
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of the Transforming Growth Factor-β Signaling Pathway in Gastrointestinal Cancers. | Biomolecules | 2023 | 37892233 | PubTator, text mining | PubMed |
| The Intergenic Type LncRNA (LINC RNA) Faces in Cancer with In Silico Scope and a Directed Lens to LINC00511: A Step toward ncRNA Precision. | Noncoding RNA | 2023 | 37888204 | PubTator, text mining | PubMed |
| NF-κB downstream miR-1262 disturbs colon cancer cell malignant behaviors by targeting FGFR1. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37867436 | PubTator, text mining | PubMed |
| Higher expression of PLEK and LY86 as the potential biomarker of carotid atherosclerosis. | Medicine (Baltimore) | 2023 | 37861500 | PubTator, text mining | PubMed |
| Editorial: MSC-derived exosomes in tissue regeneration. | Front Cell Dev Biol | 2023 | 37854070 | PubTator, text mining | PubMed |
| The HIFIA/LINC02913/IGF1R axis promotes the cell function of adipose-derived mesenchymal stem cells under hypoxia via activating the PI3K/AKT pathway. | J Transl Med | 2023 | 37848931 | PubTator, text mining | PubMed |
| GPER: An Estrogen Receptor Key in Metastasis and Tumoral Microenvironments. | Int J Mol Sci | 2023 | 37834441 | PubTator, text mining | PubMed |
| Insight into microRNAs' involvement in hematopoiesis: current standing point of findings. | Stem Cell Res Ther | 2023 | 37794439 | PubTator, text mining | PubMed |
| Identification of miRNAs Involved in Intracranial Aneurysm Rupture in Cigarette-Smoking Patients. | Neurol Ther | 2023 | 37792217 | PubTator, text mining | PubMed |
| Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2023 | 37790603 | PubTator, text mining | PubMed |
| Down-regulation of miR-424 inhibited the metastasis of endometrial carcinoma via targeting PTEN/PI3K/AKT signaling pathway. | J Cancer | 2023 | 37781075 | PubTator, text mining | PubMed |
| Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma. | J Exp Clin Cancer Res | 2023 | 37775828 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs: Blueprint in colorectal cancer metastasis and therapeutic targets. | Noncoding RNA Res | 2023 | 37767111 | PubTator, text mining | PubMed |
| Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications. | Front Immunol | 2023 | 37767098 | PubTator, text mining | PubMed |
| Successful Transfection of MicroRNA Mimics or Inhibitors in a Regular Cell Line and in Primary Cells Derived from Patients with Rheumatoid Arthritis. | Bio Protoc | 2023 | 37753465 | PubTator, text mining | PubMed |
| The Potential microRNA Prognostic Signature in HNSCCs: A Systematic Review. | Noncoding RNA | 2023 | 37736900 | PubTator, text mining | PubMed |
| Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets. | Clin Transl Med | 2023 | 37735815 | PubTator, text mining | PubMed |
| Smoking induces WEE1 expression to promote docetaxel resistance in esophageal adenocarcinoma. | Mol Ther Oncolytics | 2023 | 37732296 | PubTator, text mining | PubMed |
| Research progress on extracellular vesicles in the renal tubular injury of diabetic kidney disease. | Front Endocrinol (Lausanne) | 2023 | 37732129 | PubTator, text mining | PubMed |
| Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance. | Eur J Med Res | 2023 | 37717007 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/494336/papers?page=8